EC Number | Activating Compound | Comment | Organism | Structure |
---|---|---|---|---|
3.4.21.38 | kaolin | required for maximal activity | Bos taurus |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.4.21.38 | antithrombin III | inhibition is accelerated 300fold to 500fold by the addition of heparin, heparin alone has no effect; inhibitor is bound to the light chain of the enzyme which contains the active-site Ser residue | Bos taurus | |
3.4.21.38 | diisopropyl phosphofluoridate | inhibitor is bound to the light chain of the enzyme which contains the active-site Ser residue | Bos taurus |
EC Number | Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|---|
3.4.21.38 | 31000 | - |
1 * 31000 + 1 * 52000, SDS-PAGE | Bos taurus |
3.4.21.38 | 52000 | - |
1 * 31000 + 1 * 52000, SDS-PAGE | Bos taurus |
3.4.21.38 | 74000 | - |
sedimentation equilibrium centrifugation | Bos taurus |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.4.21.38 | Bos taurus | - |
- |
- |
EC Number | Posttranslational Modification | Comment | Organism |
---|---|---|---|
3.4.21.38 | proteolytic modification | the conversion of factor XII to factor XIIa is due to the cleavage of a specific internal Arg-Val peptide bond | Bos taurus |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.4.21.38 | blood plasma | - |
Bos taurus | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.4.21.38 | N-benzoyl-L-Phe-L-Val-L-Arg-4-nitroanilide + H2O | - |
Bos taurus | ? | - |
? | |
3.4.21.38 | tosyl arginine methyl ester + H2O | - |
Bos taurus | tosyl-Arg + methanol | - |
? |
EC Number | Subunits | Comment | Organism |
---|---|---|---|
3.4.21.38 | dimer | 1 * 31000 + 1 * 52000, SDS-PAGE | Bos taurus |